KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Non Operating Income (2016 - 2026)

Evolent Health has reported Non Operating Income over the past 9 years, most recently at $252000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income fell 33.86% year-over-year to $252000.0; the TTM value through Dec 2025 reached $249000.0, up 3.32%, while the annual FY2025 figure was $249000.0, 3.32% up from the prior year.
  • Non Operating Income for Q4 2025 was $252000.0 at Evolent Health, up from $80000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $381000.0 in Q4 2024 and troughed at -$345000.0 in Q3 2022.
  • A 5-year average of -$7100.0 and a median of -$38000.0 in 2021 define the central range for Non Operating Income.
  • On a YoY basis, Non Operating Income climbed as much as 1750.0% in 2022 and fell as far as 741.46% in 2022.
  • Year by year, Non Operating Income stood at -$73000.0 in 2021, then changed by 0.0% to -$73000.0 in 2022, then tumbled by 201.37% to -$220000.0 in 2023, then skyrocketed by 273.18% to $381000.0 in 2024, then plummeted by 33.86% to $252000.0 in 2025.
  • Business Quant data shows Non Operating Income for EVH at $252000.0 in Q4 2025, $80000.0 in Q3 2025, and -$35000.0 in Q2 2025.